A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M
|
|||||
|
|
 One comment - (Comments are closed)  Finance, Intellectual property  biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
An analysis of gut microbes from elite athletes identified a particular bacterial strain, which in tests with lab mice boosted their exercise endurance. . . . → Read More: Gut Microbe Linked to Longer Exercise Endurance Comments are closed New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
Tests of synthetic cannabidiol, or CBD, show the compound is as effective as current antibiotics against a class of microbes that includes Staphyloccocus and Streptococcus bacteria. . . . → Read More: CBD Shown Effective Against Staph, Strep Bacteria Comments are closed Joint ventures/collaborations, New products Australia, biomedical, biotechnology, life sciences, pharmaceuticals, preclinical, university 
A drug targeting immune system enzymes used as a skin cream is shown in a clinical trial to reverse effects of vitiligo, or loss of skin coloring. . . . → Read More: Topical Immune Drug Reverses Skin Disease Comments are closed New products biomedical, biotechnology, clinical trials, Europe, life sciences, pharmaceuticals, university 
A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy. . . . → Read More: Foundation Supports Muscular Dystrophy RNA Therapy Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, grant, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital 
Biochemistry labs in the U.S. and Mexico isolated and synthesized key compounds from scorpion venom that kills bacteria resistant to antibiotics. . . . → Read More: Antibiotics Synthesized from Scorpion Venom One comment - (Comments are closed) New products biomedical, biotechnology, chemistry, life sciences, pharmaceuticals, physical sciences, preclinical, university 
The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin. . . . → Read More: DoD Funding Vaccine, Therapy Delivery Device Comments are closed Finance, New products biomedical, biotechnology, clinical trials, DoD, engineering, grant, licensing, life sciences, medical device, pharmaceuticals 
Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease. . . . → Read More: Engineered Antibody Delays Type 1 Diabetes Onset One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, life sciences, NIH, pharmaceuticals 
Lab mice with bacteria transplanted from human intestines show signs that autism behaviors may result from the state of their gut microbes. . . . → Read More: Gut Microbe Links to Autism Revealed Comments are closed New products biomedical, biotechnology, entrepreneurs, life sciences, pharmaceuticals, preclinical, university 
Cancer researchers designed a technique using gold nanoscale particles for safer delivery of edited gene therapies to blood-forming stem cells. . . . → Read More: Gold Nanoparticles Boost Crispr Delivery Comments are closed New products biomedical, biotechnology, cancer, chemistry, genomics, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, preclinical, stem cells |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||